Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington's disease.
Saved in:
| Title: | Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington's disease. |
|---|---|
| Authors: | Bijlsma EK; Clinical Genetics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands e.k.bijlsma@lumc.nl., Koopmann TT; Clinical Genetics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands., de Bot ST; Neurology, Leiden University Medical Center, Leiden, The Netherlands., Losekoot M; Clinical Genetics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands. |
| Source: | Journal of medical genetics [J Med Genet] 2026 Jun 25; Vol. 63 (7), pp. 463-465. Date of Electronic Publication: 2026 Jun 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1468-6244 |
|---|---|
| DOI: | 10.1136/jmg-2026-111509 |
